| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:74576914:2377 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:74576914:2377?format=raw |
LEADER: 02377mam a2200313 a 4500
001 4059849
005 20221027025853.0
008 990319s1999 caua b 001 0 eng d
015 $aGB99-Y4940
020 $a0124205100
035 $a(OCoLC)ocm41072679
035 $9APG2564HS
035 $a4059849
040 $aUKM$cUKM$dCOU$dNNC-M$dOrLoB-B
082 04 $a572.7$221
100 1 $aDunn, Ben M.$0http://id.loc.gov/authorities/names/n88211944
245 10 $aProteases of infectious agents /$cedited by Ben M. dunn.
260 $aSan Diego, Calif. ;$aLondon :$bAcademic,$c1999.
300 $axvii, 282 pages :$billustrations (some color) ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
505 00 $g1.$tHIV Protease as a Target for the Design of Antiviral Agents for AIDS /$rJohn W. Erickson and Michael A. Eissenstat --$g2.$tProteases of the Hepatitis C Virus /$rAndrea Urbani, Raffaele De Francesco and Christian Steinkuhler --$g3.$tHuman Herpesvirus Proteases /$rXiayang Qiu and Sherin S. Abdel-Meguid --$g4.$tThe Secreted Proteinases from Candida: Challenges for Structure-Aided Drug Design /$rKent Stewart, Robert C. Goldman and Cele Abad-Zapatero --$g5.$tProteolytic Enzymes of the Viruses of the Family Picornaviridae /$rErnst M. Bergmann and Michael N. G. James --$g6.$tProteases as Drug Targets for the Treatment of Malaria /$rColin Berry --$g7.$tChagas Disease /$rJuan Jose Cazzulo --$g8.$tCellular Proteinases and Viral Infection: Influenza Virus, Sendai Virus, and HIV-1 /$rHiroshi Kido, Ye Chen and Meiko Murakami /$r[et al.] --$g9.$tBacterial Type I Signal Peptidases /$rMark O. Lively --
505 80 $g10.$tProteinases Involved in Plant Virus Genome Expression /$rJuan Antonio Garcia, Maria Rosario Fernandez-Fernandez and Juan Jose Lopez-Moya.
520 $aProteases of Infectious Agents collects reviews from leading exports describing the latest information on the properties of key enzymes from a variety of fungi, viruses, and parasites. Each chapter provides the critical facts needed to initiate a drug discovery effort in that particular area.
650 4 $aProteolytic enzymes.
650 4 $aCommunicable diseases.
650 12 $aProtease Inhibitors.$0https://id.nlm.nih.gov/mesh/D011480
650 22 $aCommunicable Diseases$xtherapy.$0https://id.nlm.nih.gov/mesh/D003141Q000628
852 00 $boff,hsl$hQP609.P78$iD86 1999